Luliconazole: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
LUZU (luliconazole) Cream, 1% for topical use | '''LUZU<sup>®</sup>''' (luliconazole) Cream, 1% for topical use | ||
Initial U.S. Approval: 2013 | Initial U.S. Approval: 2013 | ||
==Category== | ==Category== | ||
Antifungal | Antifungal | ||
==US Brand Names== | ==US Brand Names== | ||
LUZU<sup>®</sup> | '''LUZU<sup>®</sup>''' | ||
==FDA Package Insert== | ==FDA Package Insert== | ||
Revision as of 15:58, 8 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Overview
LUZU® (luliconazole) Cream, 1% for topical use Initial U.S. Approval: 2013
Category
Antifungal
US Brand Names
LUZU®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Adverse Reactions | Drug Interactions | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages
Mechanism of Action
Azole class